Eton Pharmaceuticals, Inc. Increase (Decrease) in Inventories
Eton Pharmaceuticals, Inc. (ETON) reported Increase (Decrease) in Inventories of -$4.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-13
- Eton Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$3.32M, a 129.17% decline year-over-year.
- Eton Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$1.41M.
- Eton Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $581.00K, a 28.45% decline year-over-year.
- Eton Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$5.72M.
- Eton Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2025 was $5.88M, a 219.52% increase from fiscal 2024.
- Eton Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2024 was $1.84M, a 398.37% increase from fiscal 2023.
- Eton Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2023 was $369.00K, a 5171.43% increase from fiscal 2022.
- Eton Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2022 was $7.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.72M 10-Q · filed 2026-08-13 | -$4.14M derived: sum of 3 quarters · filed 2026-08-13 | -$9.87M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$1.41M 10-Q · filed 2026-05-14 | -$825.00K derived: sum of 2 quarters · filed 2026-05-14 | -$6.55M derived: sum of 3 quarters · filed 2026-05-14 | $4.83M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $581.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$5.14M derived: sum of 2 quarters · filed 2026-03-19 | $6.23M derived: sum of 3 quarters · filed 2026-08-13 | $5.88M 10-K · filed 2026-03-19 | |||
| 2025-09-30 | -$5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.65M derived: sum of 2 quarters · filed 2026-08-13 | $5.29M 10-Q · filed 2025-11-06 | $6.11M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $11.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $11.02M 10-Q · filed 2026-08-13 | $10.91M 10-Q · filed 2025-08-07 | $11.83M derived: sum of 3 quarters · filed 2026-08-13 | $11.70M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$358.00K 10-Q · filed 2026-05-14 | -$468.00K 10-Q · filed 2025-05-13 | $454.00K derived: sum of 2 quarters · filed 2026-05-14 | $324.00K derived: sum of 3 quarters · filed 2026-05-14 | $74.00K derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $812.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $682.00K derived: sum of 2 quarters · filed 2026-03-19 | $432.00K derived: sum of 3 quarters · filed 2026-03-19 | $1.84M 10-K · filed 2026-03-19 | $1.31M 10-K · filed 2025-03-18 | ||
| 2024-09-30 | -$130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$380.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.03M 10-Q · filed 2025-11-06 | $902.00K derived: sum of 4 quarters · filed 2026-03-19 | |||
| 2024-06-30 | -$250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.16M 10-Q · filed 2025-08-07 | $1.03M derived: sum of 3 quarters · filed 2026-03-19 | $1.27M derived: sum of 4 quarters · filed 2026-03-19 | |||
| 2024-03-31 | $1.41M 10-Q · filed 2025-05-13 | $1.28M derived: sum of 2 quarters · filed 2026-03-19 | $1.52M derived: sum of 3 quarters · filed 2026-03-19 | $1.90M derived: sum of 4 quarters · filed 2026-03-19 | |||
| 2023-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $110.00K derived: sum of 2 quarters · filed 2026-03-19 | $489.00K derived: sum of 3 quarters · filed 2026-03-19 | $369.00K 10-K · filed 2026-03-19 | $354.00K 10-K · filed 2024-03-14 | ||
| 2023-09-30 | $235.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $614.00K derived: sum of 2 quarters · filed 2024-11-12 | $494.00K 10-Q · filed 2024-11-12 | $570.00K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | $379.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $259.00K 10-Q · filed 2024-08-08 | $335.00K derived: sum of 3 quarters · filed 2025-03-18 | $285.00K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | -$120.00K 10-Q · filed 2024-05-09 | -$44.00K derived: sum of 2 quarters · filed 2025-03-18 | -$94.00K derived: sum of 3 quarters · filed 2025-03-18 | -$73.00K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $26.00K derived: sum of 2 quarters · filed 2025-03-18 | $47.00K derived: sum of 3 quarters · filed 2025-03-18 | $7.00K 10-K · filed 2025-03-18 | |||
| 2022-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$29.00K derived: sum of 2 quarters · filed 2023-11-09 | -$69.00K 10-Q · filed 2023-11-09 | $147.00K derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$19.00K 10-Q · filed 2023-08-10 | $197.00K derived: sum of 3 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | -$40.00K 10-Q · filed 2023-05-11 | $176.00K derived: sum of 2 quarters · filed 2024-03-14 | |||||
| 2021-12-31 | $216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$692.00K 10-K · filed 2024-03-14 | |||||
| 2021-09-30 | -$908.00K 10-Q · filed 2022-11-10 | ||||||
| 2021-03-31 | $106.00K 10-Q · filed 2022-05-12 | -$351.00K derived: sum of 2 quarters · filed 2023-03-16 | -$361.00K derived: sum of 3 quarters · filed 2023-03-16 | -$378.00K derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2020-12-31 | -$457.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$467.00K derived: sum of 2 quarters · filed 2023-03-16 | -$484.00K derived: sum of 3 quarters · filed 2023-03-16 | $862.00K 10-K · filed 2023-03-16 | |||
| 2020-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-16 | -$27.00K derived: sum of 2 quarters · filed 2021-11-16 | $1.32M 10-Q · filed 2021-11-16 | ||||
| 2020-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $1.33M 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | $1.35M 10-Q · filed 2021-05-13 | ||||||
| 2019-12-31 | $380.00K 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |